MCC
EBS icon

Money Concepts Capital’s Emergent Biosolutions EBS Stock Holding History

Money Concepts Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$2.36K – 1130
2022
Q4 		$2.36K Buy
+200
New +$3.1K ﹤0.01% 2629
2022
Q2 		– Sell
-200
Closed -$8K – 1735
2022
Q1 		$8K Buy
+200
New +$8.82K ﹤0.01% 2023
2021
Q1 		– Sell
-2,424
Closed -$217K – 727
2020
Q4 		$217K Buy
+2,424
New +$222K 0.02% 397

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Money Concepts Capital's EBS Position: Q1 2023 in Review

Money Concepts Capital sold out of Emergent Biosolutions (EBS) in Q1 2023, closing a stake of 200 shares — an estimated $2.36K sold.

Money Concepts Capital first reported a position in EBS in Q4 2020 and held it in 3 quarters. The position peaked at $217K in Q4 2020. 191 funds tracked by Wall St. Rank hold EBS as of Q1 2023.

  • Money Concepts Capital reported no remaining Emergent Biosolutions position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 200 Emergent Biosolutions shares in Q1 2023, an estimated $2.36K.
  • Money Concepts Capital first reported a position in Emergent Biosolutions in Q4 2020 and held it in 3 quarters.
  • Money Concepts Capital's Emergent Biosolutions position peaked at $217K in Q4 2020.
  • 191 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.